This invention provides compositions and methods for identification of
carriers of Hereditary Equine Regional Dermal Asthenia (HERDA) in equine
species. In particular, this invention identifies a single nucleotide
polymorphorism (SNP) in cyclophlin B that can be used to identify
carriers of HERDA and individuals affected by HERDA.